Glucose Health, Inc.

Glucose Health, Inc.

GLUC
Glucose Health, Inc.US flagOther OTC
0.37
USD
+0.00
- -
6.27MMarket Cap
Glucose Health, Inc.
GLUC
(Other OTC)

Recent

price

0.37

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
TTM
FRC
2.47
2.24
0.99
0.07
- -
- -
- -
- -
- -
0.11
0.02
Revenue per Share
-4.21
-22.95
-29.99
-17.34
-12.4
-2.62
-4.91
-0.99
-0.14
-0.15
-0.02
Basic EPS, GAAP
-6.8
-10.6
-3.43
-3
-0.32
-0.55
-0.44
-0.2
-0.06
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-3.6
-25.22
-48.87
-58.22
-41.06
-22.57
-16.49
-8.25
-2.98
-2.24
-1.66
Book Value per Share
4.24
-3.71
-12.5
-16.29
-5.41
-1.21
-0.67
-0.58
-0.26
-0.22
-0.14
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
1
2
3
4
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-170.36
-1,016.29
-2,998.95
-25,554.82
- -
- -
-477,358.93
-19,905.66
-3,655.74
-27.66
-36.82
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-1
-1
-1
- -
-1
-1
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-170.36
-1,024.82
-3,016.03
-26,298.5
- -
- -
-651,404.46
-24,439.91
-6,228.09
-131.04
-96.52
Profit Margin (%)
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5.62
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'17
Jun'17
Sep'17
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
4
5
Market Capitalization
- -
- -
1

Working Capital

FRC

in mil. unless spec.
Mar'17
Jun'17
Sep'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-198.98%
27.75%
Free Cash Flow
- -
47.77%
-66.09%
Net Income, GAAP
- -
29.98%
54.26%
Sales/Revenue/Turnover
- -
- -
7,232.14%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available
Business
Glucose Health, Inc. (OTC: GLUC) develops, manufactures, markets and distributes soluble fiber-infused nutritional beverages targeting diabetic, pre-diabetic and health-conscious consumers; its core products include the GlucoDown trademarked iced tea mixes in flavors such as Peach Tea, Lemon Tea, Raspberry Tea and Super Berry Tea, infused with resistant dextrin soluble fiber, vitamins, minerals and Banaba Leaf extract; the Fiber Up trademarked ready-to-drink and drink mix beverages, offering nutritional benefits for individuals over 45; and related dietary supplements compliant with FDA Current Good Manufacturing Practices. The company operates primarily in North America, with distribution through Amazon, diabetic sections of the nation's two largest pharmacy chains and other retail channels; revenues approach $1.1 million in recent fiscal years with gross margins above 40%. Founded in 2007 and headquartered in Bentonville, Arkansas, Glucose Health focuses on the consumer healthcare and diabetic nutrition segments. Recent leadership changes include the appointment of Mark Schaftlein as chief executive officer and board member and Marc Hatch as chief financial officer and chief operating officer, effective October 20, 2025, following the resignation of prior CEO and CFO Murray Fleming on September 30, 2025; Fleming continues as a director for transition; Christopher J. Jemapete, an early strategic investor since 2017, joined the board on October 29, 2025; a core investor group committed nearly $2 million in cumulative direct investments; and pharmacy retail distribution doubled store count amid brand expansion. The patent-pending soluble fiber formula supports competitive positioning against brands like Glucerna and Metamucil.

Company News

APIChat
  • Critical Survey: Glucose Health (OTCMKTS:GLUC) versus GE HealthCare Technologies (NASDAQ:GEHC)

  • Financial Survey: Glucose Health (OTCMKTS:GLUC) versus EssilorLuxottica (OTCMKTS:ESLOY)

  • Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign

  • Financial Contrast: Glucose Health (OTCMKTS:GLUC) vs. Abbott Laboratories (NYSE:ABT)

  • High Tide (NASDAQ:HITI) vs. Glucose Health (OTCMKTS:GLUC) Critical Review

  • Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand

  • Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

  • Capricor Therapeutics (NASDAQ:CAPR) versus Glucose Health (OTCMKTS:GLUC) Head to Head Survey

  • Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

  • Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors

  • Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors

  • Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025

  • Glucose Health, Inc. (OTC: GLUC) Highlights U.S. Department of Health and Human Services Designation of Key Nutrient Validating Company's Patent-Pending Nutrition Formulation via CNBC, Fox Business and Bloomberg Television Media Blitz

  • Glucose Health, Inc. Formulations Have Always Been Free of Artificial Colors & Synthetic Dyes—Our Competitors Are Only Playing Catch-Up

  • U.S. Department of Health and Human Services Designates Four Nutrients of Public Health Concern Validating Glucose Health, Inc. (OTC: GLUC) Patent Pending Soluble Fiber-Based Nutrition Formulation

  • Glucose Health, Inc. Announces Expansion of Fiber Up® Brand – More Drink Mix Flavors and New Fiber Up® Gumdrops

  • USPTO Grants Registered Trademark Status for "Fiber UP" – An Innovative New Breakthrough In Fiber Supplementation From Glucose Health, Inc. (OTCPK: GLUC)

  • GLUCODOWN® Brand Achieves 10,000 Top Reviews at Amazon

  • First GLUCODOWN® Spanish Language Advertising Campaign Sparks Sales Growth at Amazon

  • Glucose Health, Inc.: Why We See A Major Turnaround Coming